#USA #New York #Securities Fraud #Rosen Law Firm #Ardelyx

Opportunity for Investors in Ardelyx, Inc. Suit

Investors in Ardelyx, Inc. (NASDAQ: ARDX) who acquired shares from January 13, 2025, through August 6, 2026, are being reminded of an important deadline regarding a securities fraud class action. The Rosen Law Firm, a prominent global investor rights legal firm, is urging those affected to consider participating by becoming lead plaintiffs in the case. This announcement serves as a crucial reminder as the deadline to take action is set for November 16, 2026.

Why Take Action?

If you purchased Ardelyx common stock during the specified period, you could be entitled to compensation without any out-of-pocket expenses, thanks to a contingency fee arrangement. This means that claimants will not have to pay any legal fees unless they achieve a successful resolution of the case. The Rosen Law Firm emphasizes the importance of acting before the deadline for those wishing to join the class action.

Join the Ardelyx Class Action or call Phillip Kim, Esq. at 866-767-3653 for further information about this lawsuit.

Background on the Class Action

The class action was initiated based on allegations that Ardelyx, Inc. made misleading public statements regarding the company's performance and the prospects of its products, specifically XPHOZAH and IBSRELA. The complaint claims that during the class period, Ardelyx provided overly positive assessments while concealing crucial information about significant barriers to accessing these products, particularly regarding payer-related access, reimbursement obstacles, and strict prior authorization requirements. These factors contributed to delays in patients starting new treatments and fulfilling prescriptions.

When the realities of Ardelyx's market situation became evident, the lawsuit posits that investors faced significant financial losses.

What Steps Should You Take?

To be a lead plaintiff— a representative party in the lawsuit— interested parties must act promptly and file their motions with the Court before the deadline of November 16, 2026. The role of a lead plaintiff is vital as they guide the proceedings on behalf of all class members.

It's crucial for investors to select a law firm with a solid understanding of securities class actions and a proven record of achieving favorable outcomes. The Rosen Law Firm is noted for successfully recovering billions of dollars for investors and being recognized for their excellence in this specialized field.

The Rosen Law Firm’s Credentials

The Rosen Law Firm has distinguished itself as a leader in securities class action, securing the highest settlement ever against a Chinese company and consistently ranking among the top firms for class action settlements since 2013. Their achievements underscore a strong commitment to investor rights, making them a preferred choice for those involved in securities litigation.

If you are an investor affected by Ardelyx's alleged misconduct, now is the time to consider your options for participation in the class action.

Stay Informed

Keep abreast of developments around this case through Rosen Law Firm’s social media channels, including LinkedIn, Twitter, and Facebook. Their continuous updates can provide valuable insights as the class action progresses.

For further inquiries, please contact:

• - Laurence Rosen, Esq.
• - Phillip Kim, Esq.
• - The Rosen Law Firm, P.A.
• - 275 Madison Avenue, 40th Floor, New York, NY 10016
• - Tel: (212) 686-1060 | Toll-Free: (866) 767-3653
• - Email: [email protected]

In conclusion, Ardelyx investors must act swiftly to protect their rights and potentially recover damages incurred due to the company’s alleged fraudulent actions. Joining the class action could provide a pathway for compensation and accountability for wrongful actions that have affected the value of their investments.